Cencora Inc. stock underperforms Wednesday when compared to competitors
Shares of Cencora Inc. COR slid 2.56% to $254.00 Wednesday, on what proved to be an all-around mixed trading session for the ...
Cencora, Inc. (COR): Among Stocks With At Least $30 Million In Insider Sales Recently
We recently published a list of 10 Stocks With At Least $30 Million In Insider Sales Recently. In this article, we are going ...
Barchart on MSN1d
Is Cencora Stock Outperforming the Nasdaq?
With a market cap of $50.5 billion, Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a global healthcare solutions ...
Cencora (NYSE:COR) Eyes Acquisitions and Technology Investments with Potential OneOncology Buyout
Cencora (NYSE:COR) has made headlines with its announcement on March 10, 2025, detailing plans for strategic acquisitions and investments in technology infrastructure, aiming to drive future growth.
Here's Why Cencora (COR) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cencora: Higher Potential Returns After Reduced Walgreens Stake
Cencora offers steady revenue growth from pharmaceutical distribution, benefiting from rising healthcare demand and an aging ...
PharmExec9h
Emerging Biopharma Launches: Strategizing in Today’s Global Market
John Arena is interim president of global pharma services at Cencora, managing a team that offers a broad range of solutions ...
Cencora price target raised to $280 from $270 at Argus
Argus analyst David Toung raised the firm’s price target on Cencora (COR) to $280 from $270 and keeps a Buy rating on the shares. The company ...
Cencora Inc. stock outperforms competitors on strong trading day
Shares of Cencora Inc. COR advanced 1.82% to $253.54 Friday, on what proved to be an all-around favorable trading session for ...